Insiders who have reported open-market trades at the same companies as Mark David Novara. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Mark David Novara is a corporate insider, tracked as EVP & CHIEF COMMERCIAL OFFICER of TANDEM DIABETES CARE INC (TNDM). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mark David Novara last file a Form 4?
The most recent primary Form 4 on record is dated 19 May 2026, one of 9 filings going back to 2024.
Has Mark David Novara been buying or selling stock?
Recorded transactions: 1 open-market purchase ($12K) and 2 open-market sales ($4K) across all tracked filings.
Mark David Novara is EVP & CHIEF COMMERCIAL OFFICER of TANDEM DIABETES CARE INC (TNDM). 9 SEC Form 4 filings on record going back to 2024, most recently on 19 May 2026. Most recent open-market trade: sold $4K of TNDM on 18 March 2026. Lifetime open-market purchases: $12K. Lifetime open-market sales: $4K.
Recent transactions
19
The latest 19 SEC Form 4 transactions reported by Mark David Novara.
InsiderAlpha's records for Mark David Novara go back to 2024: 9 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $12K (1 buy totaling $12K). The largest single buy on record is $12K of TNDM in 2024. Sales side: 2 recorded sales totaling $4K, so the filing history runs buy-heavy by dollar value. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
